A distinct innate immune signature marks progression from mild to severe COVID-19

Coronavirus disease 2019 (COVID-19) manifests with a range of severities, but immune signatures of mild and severe disease are still not fully understood. Here, we use mass cytometry and targeted proteomics to profile the innate immune response of patients with mild or severe COVID-19 and of healthy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Rep Med
Autori principali: Chevrier, Stéphane, Zurbuchen, Yves, Cervia, Carlo, Adamo, Sarah, Raeber, Miro E., de Souza, Natalie, Sivapatham, Sujana, Jacobs, Andrea, Bachli, Esther, Rudiger, Alain, Stüssi-Helbling, Melina, Huber, Lars C., Schaer, Dominik J., Nilsson, Jakob, Boyman, Onur, Bodenmiller, Bernd
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817872/
https://ncbi.nlm.nih.gov/pubmed/33521697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100166
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi